rdf:type |
|
lifeskim:mentions |
umls-concept:C0006100,
umls-concept:C0016030,
umls-concept:C0086418,
umls-concept:C0127400,
umls-concept:C0205314,
umls-concept:C0205464,
umls-concept:C0679622,
umls-concept:C0680242,
umls-concept:C0914912,
umls-concept:C1280500,
umls-concept:C1550315,
umls-concept:C1880022
|
pubmed:issue |
8
|
pubmed:dateCreated |
2009-12-18
|
pubmed:abstractText |
Bradykinin (BK) and B2 receptors have been implicated in the pathophysiology of osteoarthritis (OA), and synovitis is one of its hallmarks. Here, the selective B2 receptor antagonists MEN16132 and icatibant have been pharmacologically characterized in human synovial cells.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/(4-amino-5-(4-(4-(2,4-dichloro-3-(2...,
http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin,
http://linkedlifedata.com/resource/pubmed/chemical/Inositol Phosphates,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8,
http://linkedlifedata.com/resource/pubmed/chemical/Ornithine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Bradykinin B2,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/icatibant
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1476-5381
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
158
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1996-2004
|
pubmed:dateRevised |
2011-3-3
|
pubmed:meshHeading |
pubmed-meshheading:20050188-Bradykinin,
pubmed-meshheading:20050188-Cells, Cultured,
pubmed-meshheading:20050188-Fibroblasts,
pubmed-meshheading:20050188-Humans,
pubmed-meshheading:20050188-Inhibitory Concentration 50,
pubmed-meshheading:20050188-Inositol Phosphates,
pubmed-meshheading:20050188-Interleukin-6,
pubmed-meshheading:20050188-Interleukin-8,
pubmed-meshheading:20050188-Ornithine,
pubmed-meshheading:20050188-Radioligand Assay,
pubmed-meshheading:20050188-Receptor, Bradykinin B2,
pubmed-meshheading:20050188-Sulfonamides,
pubmed-meshheading:20050188-Synovial Membrane,
pubmed-meshheading:20050188-Synovitis
|
pubmed:year |
2009
|
pubmed:articleTitle |
Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts.
|
pubmed:affiliation |
Department of Pharmacology, Menarini Ricerche SpA, Florence, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|